Short title: Retention in the endoplasmic reticulum
INTRODUCTION 44 45
Since the discovery of the vectorial nature of the secretory pathway linking the endoplasmic 46 reticulum (ER) via the Golgi apparatus to the plasma membrane (Palade, 1975) , it has become 47 clear that it is one of the most ancient innovations of the emerging eukaryotes. The discovery 48 apparatus ( Figure 4C ) whilst YFP-ERD2 was difficult to detect and trapped in the ER (Figure  257 4D). The localization result for ERD2-YFP is in agreement with earlier studies using similar C-258 terminal ERD2 fusions but contradict a study showing that such a fusion can reduce secretion 259 of HDEL proteins (Montesinos et al., 2014) . 260
Very low expression and ER retention of YFP-ERD2 may be indicative of severe misfolding, 261 perhaps by flipping the orientation of ERD2 in the membrane. We thus introduced an N-262 terminal signal peptide and a short decapeptide harbouring an N-linked glycosylation site 263 (Batoko et al., 2000) to the N-terminus of YFP-ERD2. Figure 4B shows that the resulting 264 construct (secYFP-ERD2) still failed to show any biological activity. However, in sharp contrast 265 to YFP-ERD2, secYFP-ERD2 labelled exclusively punctate structures ( Figure 4E ) and was 266 now well expressed. Co-expression with the Golgi-marker ST-RFP confirmed that the 267 structures are indeed Golgi bodies (Supplemental Figure 2A) . When co-expressed with the 268 ERD2-cargo RFP-HDEL, no co-localization was detected (Supplemental Figure 2B) . 269
Finally, we re-created an internal fusion protein which places YFP within the first predicted 270 cytosolic loop of ERD2 (Supplemental Figure 3A) . This fusion was originally reported as being 271
The most dramatic difference was observed between ER-retained YFP-ERD2 and the Golgi 290 resident secYFP-ERD2. Since signal peptides are cleaved, only a flipped membrane topology 291 can explain such a different fate of the fusion protein. To investigate this further, we first tagged 292 the new secYFP-ERD2 construct with RFP at its C-terminus. The resulting construct secYFP-293 ERD2-RFP was well expressed and showed a dual ER-Golgi localization in both channels 294 ( Figure 4F ), similar to ERD2-YFP ( Figure 4C ). This shows that the secYFP portion does not 295 cause dominant Golgi retention and that C-terminal tagging promotes partial ER localization of 296 ERD2-fusions. The YFP portion was shown to be glycosylated ( Figure 4G ) as observed by a 297 size shift of the full-length fusion protein fusion induced by the N-linked glycosylation inhibitor 298 tunicamycin (T), suggesting that the YFP portion is lumenal. A similar dual expression 299 construct without an N-terminal signal peptide (YFP-ERD2-RFP) was very poorly expressed 300 and only weakly detected in the ER (data not shown), similar to YFP-ERD2 ( Figure 4D ). By 301 contrast, secYFP-ERD2 protein levels are high, it readily leaves the ER and accumulates in the 302 10 Golgi, which suggests that it is correctly folded. We concluded that a lumenal N-terminus is 303 essential to mediate ER export and high expression of ERD2 at the Golgi apparatus. 304 ( Figure 6A , black arrowhead). The molecular weight of the PF was consistent with the 351 presence of a single TM fused to RFP and it was degraded in the presence of detergent, unlike 352 the resistant RFP-core which provided a loading control. This indicates that ERD2-TM-RFP 353 produces a fusion protein with a lumenal RFP due to the additional TM domain. 354
To verify that N-termini and C-termini do not influence each other, we supplemented ERD2-355 TM-RFP with secYFP at its N-terminus, yielding secYFP-ERD2-TM-RFP that can be detected 356 with two different antibodies. The resulting larger polypeptide continues to be glycosylated, as 357 seen by the size shift of the full-length polypeptide in the presence of tunicamycin ( Figure 6A) . 358
The same size shift was seen in Figure 4F , showing that the YFP portion at the N-terminus is 359 lumenal regardless of the insertion of an additional C-terminal TM. Furthermore, protease 360 protection of secYFP-ERD2-TM-RFP microsomes revealed the same protected RFP fragment 361 (black arrow heads) as seen for ERD2-TM-RFP. This shows that presence of secYFP to the N-362 terminus did not change the membrane orientation of the ERD2 C-terminus either. 363
When probed with antibodies to YFP, the full-length secYFP-ERD2-TM-RFP fusion protein 364 (FL) also exhibited a tunicamycin-sensitive size shift ( Figure 6B ). Protease protection revealed 365 a PF corresponding to glycosylated YFP fused to the complete ERD2 polypeptide but without 366 12 the fused additional TM and RFP (black arrowheads). The results suggest that all the predicted 367 cytosolic loops of ERD2 are resistant to the protease, except for the artificially created loop at 368 the C-terminus by adding a further TM domain. Again in the presence of detergent the PF was 369 digested, leaving only the proteinase K resistant YFP-core which served as a loading control. 370
Based on these results, together with the results of Figures 4 and 5, we propose that native 371 ERD2 possesses an asymmetrical membrane topology with a lumenal N-terminus and a 372 cytosolic C-terminus. The resulting topology of the experimental constructs is illustrated in 373 Figure 6C . 374
375

ERD2 resides mainly at the cis-Golgi apparatus 376
In situ activity and subcellular localization of the new fluorescent fusion proteins was tested by 377 our in situ assay ( Figure 3B ). RFP-TM-ERD2 labelled exclusively punctate structures when co-378 expressed with ST-YFP-HDEL together with either Amy ( Figure 7A ) or Amy-HDEL ( Figure 7B ). 379
Even in the presence of the competitor Amy-HDEL, ST-YFP-HDEL always showed complete 380 retention in the ER network, with no detectable punctate structures (see Supplemental Figure 4 381 for alternative color schemes). This demonstrates that RFP-TM-ERD2 increases the ER 382 retention capacity and confirms the results from the biochemical bio-assays ( Figure 5D ) in situ. 383
The exclusively punctate labelling of RFP-TM-ERD2 was also observed for YFP-TM-ERD2 and 384 the two fusions co-localized to a high level ( Figure 7C ). Co-expression of the standard Golgi 385 marker ST-YFP with RFP-TM-ERD2 also revealed co-localization in the same structures 386 We also co-expressed the functional RFP-TM-ERD2 with the earlier constructed non-functional 413 secYFP-ERD2 for analysis using the Airyscan detector ( Figure 8C ). The very high degree of 414 co-localization shows that secYFP-ERD2 may not exhibit any protein sorting defects. separate network that connects individual Golgi bodies (illustrated in Figure 8G ). Investigations 461 into the significance of Golgi tubules were beyond the scope of this study. 462 revealed no specific residue at the C-terminus involved with ERD2 function. By contrast, 466 phosphorylation of serine 209 in the human ERD2 C-terminus was proposed to be required for 467
Golgi to ER transport (Cabrera et al., 2003) . This serine residue is not conserved in eukaryotes 468 including land plants ( Figure 9A ), but the fact that C-terminal fusions compromised the in vivo 469 activity of plant ERD2 ( Figures 4C, 5C ) hints at an important function of its C-terminus. Since 470 our bio-essay potentially reports on all aspects of ERD2 function, including the anterograde 471 transport from the ER to the Golgi, we decided to investigate the influence of specific point-472 mutations in this region. Figure 9B shows that two conserved Leucine residues were important 473 in maintaining the strong effect of untagged ERD2 in reducing Amy-HDEL secretion. Replacing 474 both residues by glycine (LLGG) resulted in a strong inhibition of ERD2 activity in the bio-assay 475
(Figure 9B, last lane). 476
To test if this lack of ERD2 activity is associated with a transport defect, the LLGG mutation 477 was introduced to the active fluorescent ERD2 fusion (YFP-TM-ERD2-LLGG) and co-478 This shows that the LLGG mutation is not a complete knockout, but it is weak by comparison 487 with YFP-TM-ERD2 and RFP-TM-ERD2 which show a clear effect even at the lowest plasmid 488 concentration ( Figure 5D ). 489
We also carried out the same over-dose experiment for ERD2-YFP, since our data are in 490 conflict with earlier published data (Montesinos et al., 2014) and we wanted to test for weak 491 residual activity. Supplemental Figure 5 shows that even at the highest plasmid concentration 492 ERD2-YFP did not show biological activity as judged by amy-HDEL secretion. The discrepancy 493 quantitative enzyme activity assays. 495
Finally, to illustrate the importance of the C-terminus, we created a deletion mutant that lacked 496 the last predicted TM domain and the cytosolic tail of ERD2 (YFP-TM-ERD2-ΔTM7). Whenexpressed in tobacco leaves, this fusion protein was exclusively found at the ER ( Figure 9E ). 498
Together with the localization of YFP-ERP1 ( Figure 5C ), this shows that exclusive Golgi 499 localization of our fusion proteins and the lack of ligand-induced re-distribution to the ER is not 500 caused by a dominant Golgi localization signal from the additional TM domain of ERP1. This is 501 also supported by the fact that Golgi residency as well as the tubular extensions were also 502 observed with secYFP-ERD2 ( Figure 4E ), which does not have an extra TM domain. 503
Together, the data explain why C-terminal ERD2 fusions are non-functional and suggest that 504 the dual ER-Golgi localization consistently reported in the literature may not reflect a 505 biologically meaningful steady state distribution of functional ERD2. Our results indicate that 506 the ERD2 C-terminus is essential for its biological function as well as its Golgi residency. 507 508 DISCUSSION 509
510
To help elucidate the role of ERD2 in cargo trafficking between the ER and the Golgi 511 apparatus, it was important to establish probes that permit distinction between the individual 512 transport steps involved. Ideally, functional studies should be able to trace both ligands and 513 receptors in vivo. Here we have successfully established new tools to do so and identified 514 unexpected transport properties of ERD2. 515 516
Gain-of-function assays reveal functional conservation of ERD2 between Arabidopsis 517 thaliana and Nicotiana benthamiana 518
We show that ectopic expression of ERD2 leads to a sensitive dose-dependent activity assay 519 in which ERD2 prevents secretion of Amy-HDEL without affecting constitutive Amy secretion 520 ( Figure 1E ). This ERD2 gain-of-function assay is specific, sensitive and quantitative, using 521 ectopic ERD2 expression levels beyond those causing a collapse of the Golgi (Hsu et al., In this respect, it should be noted that experiments with redox-sensitive GFP fused to ERD2 578 (Brach et al., 2009) did not include subcellular localisation data that may have revealed the 579 differences between C-terminal and N-terminally tagged ERD2 as observed here (Figure 4) . 580
Membrane insertion of multiple membrane spanning proteins is thought to be guided by charge 581 distributions of the first transmembrane domain (vonHeijne, 1989) . However, folding of the N-582 terminus is also thought to be important (Spiess, 1995), in particular if the N-terminus is to be 583 translocated to the ER lumen. Native ERD2 exhibits an extremely short N-terminus prior to the 584 first predicted transmembrane domain. Introducing an entire fluorescent protein to this N-585 terminus (YFP-ERD2) may trap the molecule in the wrong orientation by a folded or partially 586 YFP protein prior to translocation of the first transmembrane domain (Spiess, 1995). The 587
The best labelling strategy can only be determined by trial and error (Snapp, 2005) , and should 590 be combined with an assay for in vivo activity. Our results illustrate that extending the ERD2 N-591 terminus with YFP only resulted in high expression and ER export when either a signal peptide 592 was included in front of YFP or an additional transmembrane domain after YFP, both ensuring 593 that these tubules are distinct from the nearby ER network. Two or more adjacent Golgi bodies 610 were found to be tethered together by such tubules whilst they move (Supplemental Movie 1). 611 
ASAM in ERD2b-YFP
). This can be tested experimentally in the future using any passenger 633 protein harbouring a C-terminal HDEL or KDEL signal. 634
The critical importance of a native ERD2-C-terminus is illustrated by the fact that partial ER 635 retention is probably caused by masking of the ERD2 C-terminus. Two conserved leucines in 636 the tail are important for both Golgi residency and biological activity (Figure 9 ). This indicates 637 that the ERD2 C-terminus plays a role in its own Golgi localization as well as its ability to 638 mediate ER retention of its ligands. 639
The di-leucine motif appears to be unrelated to any earlier described Golgi localization signals 640 such as the C-terminal KXD/E motif (Gao et al., 2012). The shift in steady state levels of the 641 LLGG mutant ( Figure 9D ) could be caused by defective ER export, or accelerated Golgi-to-ER 642 recycling. However, it is difficult to explain how faster recycling would lead to the drastic 643 reduction in biological activity ( Figure 9B ; Supplemental Figure 5 ). 644
Interestingly, using the biologically active YFP-TM-ERD2 reporter, we were unable to show a 645 ligand-induced ERD2-redistribution to the ER in epidermis cells ( Figures 7B, 8D,E) . A maximal 646 ligand to receptor ratio was generated by combining a strong promoter-driven HDEL cargo with 647 a weak promoter receptor fusion (Supplemental Methods 2) for multi-copy expression from the 648 same plasmid vector ( Figure 8D, E, F) . In spite of this, YFP-TM-ERD2 remained in punctate 649 structures even though Amy-HDEL was overexpressed to saturating levels ( Figure 8F 
ERD2 plasmids 740
The coding regions of ERD2a (AT1G29330) and ERD2b (AT3G25040) were obtained via gene 741 synthesis introducing a ClaI site overlapping with the start codon and XbaI site following the 742 stop codon yielding the sequences illustrated in Supplemental Methods 2 and placed under the 743 transcriptional control of the CaMV35S promoter in the dual expression vector together with 744 TR2'-ST-CFP-3'ocs as internal marker (pAG10 and pAP10). The CaMV35S:ERD2a-3'nos and 745 CaMV35S:ERD2b-3'nos construct was also cloned in a pUC19 vector on its own (yielding 746 pAG2 and pAG3 respectively). CaMV35S:ERD2b-3'nos was also cloned into pGUSref 747 pJA51. A signal peptide and glycosylation peptide was added to generate secYFP-ERD2b by 768 extracting an EcoRI-NcoI fragment from pLL50 (Foresti et al., 2006 ) and amplifying pJA51 with 769 primer YFP/NcoI-sense (5'-CTGCCCGTGCCATGGCCCACCCTCGTGACCACC-3') and 770 pUCOF from which an NcoI-HindIII fragment was extracted. Both fragments were ligated 771 together into pJA31, cut with EcoRI-HindIII and dephosphorylated, to yield pJCA17. To 772 generate secYFP-ERD2b-RFP, we extracted an EcoRI-KpnI fragment from pJCA17 and 773 ligated it into pAG8, cut with the same two enzymes and dephosphorylated, to yield pJA72. 774 E-YFP-RD2 was generated by assembly-PCR to introduce a YFP coding region between the 775 first and the second predicted transmembrane domains of ERD2b as described (Li et al., 
ERP1 construct 787
The coding region of AtERP1 (AT4G38790) was obtained via gene synthesis introducing a ClaI 788 site overlapping with the start codon and XbaI site following the stop codon yielding the 789 sequences illustrated in Figure 5 , which was inserted as ClaI-XbaI fragment into pTFLA32 790 under the transcriptional control of the TR2' promoter (pTFLA27) to create the YFP-ERP1. 791
792
ERD2 with additional transmembrane domains 793
To add a transmembrane domain between the C-terminus of ERD2b and RFP, the sequence 794 (ERD2b-TM) was synthesized and described in Supplemental Methods 2. The sequence was 795 trimmed by ClaI-NheI and ligated into pAG8, cut with the same enzymes and 796 dephosphorylated, to yield pFLA93 encoding ERD2b-TM-RFP. The resulting hybrid coding 797 region was also ligated as a ClaI-BamHI fragment into pJA31, cut with the same enzymes and 798 dephosphorylated, to yield pFLA72. To generate secYFP-ERD2-TM-RFP, pFLA72 was cut 799 with EcoRI-KpnI and dephosphorylated, and ligated to an EcoRI-KpnI fragment extracted from 800 pJCA17, to yield pFLA92. 801
To insert a transmembrane domain and cytosolic linker between YFP and ERD2b, the 802 sequence (TM-ERD2b) was synthesized and described in Supplemental Methods 2. The 803 sequence was trimmed with ClaI-XbaI and inserted either into pJA51 cut with the same 804 enzymes and dephosphorylated, to yield pFLA30 encoding YFP-TM-ERD2b. The same 805 fragment was inserted into pJA31 using the same strategy, to yield pFLA33 encoding TM-806
ERD2b. To generate RFP-TM-ERD2b (pFLA40), we amplified the RFP coding sequence using 807 NcoI-RFP (5'-TCTATAACCATGGCCTCCTCCGAGGACGTC-3') and RFP-ClaI (5'-808 CGCCTTCATCGATGCGCCGGTGGAGTGGCGGCCCTC-3') from pAG8 as template, trimmed 809 the PCR product with NcoI-ClaI and replaced the YFP coding region in pFLA30 using the same 810 sites. 811 26 (pTJA10), YFP-ERD2b (pTOF122), secYFP-ERD2b (pTJCA24), and secYFP-ERD2b-RFP 819
(pTCSJ1). 820
For sub-cellular localization studies at low expression, chimeric coding regions were subcloned 821 under the transcriptional control of the weak TR2 promoter. For this purpose, pTFB62 was cut 822
with ClaI-HindIII, followed by dephosphorylation, to be used as vector. The ERD2b-TM-RFP-823 3'nos fragment was extracted from pFLA72 by a complete ClaI-HindIII digest to yield pTFLA94 824 after ligation to the vector. The secYFP-ERD2-3'nos fragment was obtained by partial ClaI and 825 complete HindIII digest, to yield pTFLA25. Other fluorescent ERD2 fusions had an NcoI site at 826 the start codon of the chimeric coding region and we generated a TR2 promoter fragment by 827 PCR amplification using primers PUCsense (5'-828 AAAACTCATCGATGATGGGCCGGATCTTTG-3') and TR2:NcoI (5'-829
CTTGCTCACCATGGATTTGGTGTATCGAGATTGGTTATG-3') and pAG10 (Supplemental 830
Methods 2) as template. The PCR product was digested using EcoRI-NcoI to yield the new 831 TR2 promoter fragment. Plasmids pFLA30 and pFLA40 were digested using NcoI and HindIII 832 to yield fragment YFP-TM-ERD2b-3'nos, and RFP-TM-ERD2-3'nos and ligated together with 833 the promoter fragment into pDE1001 cut with EcoRI-HindIII and dephosphorylated to yield 834 pTFLA32 and pTFLA41 (Supplemental Table 1 ). 835
836
Mutagenesis and deletions 837
Point mutations of the C-terminus of AtERD2b were created via the standard quick change 838 method and resulted in codon changes to yield amino acid substitutions as indicated in Figure  839 
840
YFP-TM-ERD2-ΔTM7 was generated by PCR using an anti-sense primer ERD2-ΔTM7 (5'-841 ATCCAGTGGCTAGCGTGCGGCTCAGTGAAGTAACGGTA-3') combined with cool35S (5'-842 CACTATCCTTCGCAAGACC-3') using pFLA30 as template. The ClaI-NheI YFP-TM-ERD2-843 27 ΔTM7 fragment was then ligated together with NheI-HindII 3'nos fragment cut from pFLA98 844 into pTFB62, cut with ClaI-HindIII, followed by dephosphorylation, to yield pTFLA106. 845
Organelle markers 847
The Golgi-marker ST-RFP was based on Agrobacterium tumefaciens dual expression vector 
Drug treatments 887
To test for N-linked glycosylation, two standard protoplast electroporations were pooled, 888 divided into equal portions, one to be supplemented with Tunicamycin to a final concentration 889 of 10μg/mL suspension whilst the control received the same amount of solvent-only (DMSO). 890
Protein Extraction 892
Proteins were extracted from protoplasts pelleted in 250mM NaCl as described before (Foresti 893 et al., 2006) using specific buffers and procedures depending on the type of experiment. 894
In order to measure α-amylase activities and also detect the internal marker ST-CFP by SDS-895 PAGE, the pellets remaining after protoplast sonication with amy-extraction buffer, 896 centrifugation and recovery of the supernatant for standard amy-assays (Foresti et al., 2006 ) 897 were kept to be extracted again by sonication in 250 μL membrane protein extraction (MPE) 898 buffer (100 mM Tris-HCl, pH 7.8, 200 mM NaCl, 1 mM EDTA, 0.2% Triton X-100, and 2% β-899 mercaptoethanol), followed by 10-min centrifugation at 19,745g at 4°C and subsequent 900 recovery of the supernatant to be mixed 50:50 with SDS-PAGE sample buffer (see below). 901
For combined GUS-normalised effector dose-response assays (Gershlick et al., 2014), 2.5 ml 902 protoplast suspension from a standard electroporation were divided into a 500 µL sample for 903 GUS analysis and a 2000 µL sample kept in a conical 10mL tube for Amy analysis. The GUS 904 sample was immediately mixed with 500 µL of GUS extraction buffer [50mM (P) Sodium buffer 905 pH 7.0; 10mM Na2EDTA; 0.1% sodium lauryl sarcosine; 0.1% Triton X-100 and 10 mM β-906 Mercaptoethanol] and transferred to ice. The mixed GUS extraction samples on ice (1 ml) were 907 29 first sonicated (60% for 5s), vortexed and centrifuged at 14,000 rpm (Sigma 12132 rotor) and 908 4°C for 15 minutes, after which 500 µL supernatant was recovered and kept on ice. The amy 909 sample was centrifuged to recover cell-free medium as well as washed cells and all further 910 steps to measure cellular and secreted α-amylase activity measurement as described before 911 (Foresti et al., 2006) , but implementing volumetric calculations based on 2mL total suspension, 912 rather than the standard 2.5 ml. 913
For standard SDS-PAGE of ERD2 fusion proteins, cell pellets were extracted in MPE buffer. 914 Figure 1E , but comparing ERD2a with ERD2b on amy-HDEL and using lower amounts of effector plasmids (indicated below each lane in µg). Notice the lack of any difference between ERD2a or ERD2b. B) Identical experiment as panel A, but with amy-KDEL as cargo instead of Amy-HDEL. C) Illustration of the hybrid ERD2 transcript (NbERD2ab) which was generated as sense and as anti-sense constructs. The alignment shows the point where the fusion was made to generate a hybrid ERD2 coding region. D) Transient expression experiment with Nicotiana benthamiana protoplasts co-expressing Amy-HDEL with either AtERD2b, sense NbERD2ab, antisense NbERD2ab (AS) or the combination of AS with AtERD2b and incubated for 48 hours to allow degradation of endogenous ERD2. 50 µg of cargo plasmid was electroporated alone or co-electroporated together with sense or antisense ERD2 plasmids as indicated by "+". Error bars are standard deviations of three independent transfections. Figure  1A ,B for alternative colour combinations.
